Insider Transactions in Q4 2022 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2022
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+4.52%
|
$8,000
$2.08 P/Share
|
|
Dec 22
2022
|
Mike Ouimette General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct |
2,928
-32.99%
|
$55,632
$19.38 P/Share
|
|
Dec 20
2022
|
Hans Hull Chief Business Officer |
SELL
Open market or private sale
|
Direct |
8,748
-5.95%
|
$166,212
$19.1 P/Share
|
|
Dec 20
2022
|
Mike Ouimette General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct |
4,719
-34.71%
|
$89,661
$19.1 P/Share
|
|
Dec 20
2022
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,887
-7.01%
|
$206,853
$19.1 P/Share
|
|
Dec 20
2022
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Direct |
34,212
-26.72%
|
$650,028
$19.1 P/Share
|
|
Dec 20
2022
|
Keith Lamont Cummings Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,643
-10.71%
|
$183,217
$19.1 P/Share
|
|
Dec 19
2022
|
Hans Hull Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,578
+10.68%
|
-
|
|
Dec 19
2022
|
Mike Ouimette General Counsel & Corp. Sec'y |
BUY
Grant, award, or other acquisition
|
Direct |
13,594
+50.0%
|
-
|
|
Dec 19
2022
|
Eric Lefebvre Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,876
+12.35%
|
-
|
|
Dec 19
2022
|
Bernard Coulie President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
68,751
+34.94%
|
-
|
|
Dec 19
2022
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,375
+17.7%
|
-
|
|
Nov 29
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,000,000
-52.09%
|
-
|
|
Oct 25
2022
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.61%
|
$125,000
$25.05 P/Share
|